Big science is about advancing the frontiers of knowledge. But it is also the source of extraordinary innovation, with huge commercial value and societal impact. So how can Europe become more systematic in extracting this value?
A new online platform ShareIn is connecting biotech companies with investors. This is forcing traditional funders to up their game and cut back on layers of intermediary costs for start-ups, says Jude Cook, co-founder of ShareIn
A £195M fund to address antimicrobial resistance and a $100M VC fund to spur drug discovery in dementia, both announced by the UK government this week, aim to build international coalitions to deal with these threats
Two major projects in the UK and the US are investigating the use of drones in monitoring illegal fishing. The researchers presented their wares in Brussels this week
With success rates hovering at 14-15%, the EU is weighing the options and considering referring rejected scientists with good proposals to another source of funding
Digital technologies can help older adults maintain independence and assist with their care. But resistance to change and a shortage of objective data to help communicate its value, is making it hard to commercialise products and build markets, says Martijn Vastenburg
The EU has become more innovative in recent years and as a result the innovation gap with the US and Japan has been reduced. But Europe is still lagging, according the latest data from Eurostat
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.